VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Age : from 20 to 90 y/o                            │ Age : from 20 to 90 y/o                            │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Inflammatory arthritis patients who plan to treat  │ Inflammatory arthritis patients who plan to treat  │     100 │
│ with biological agents, including Humira or Enbrel │ with biological agents, including Humira or Enbrel │         │
│ or Simponi or Orencia or Mabthera or Actemra; as   │ or Simponi or Orencia or Mabthera or Actemra; as   │         │
│ first line biologic treatment is indicated         │ first line biologic treatment is indicated         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ HCV, HIV, or HDV coinfection                       │ HCV, HIV, or HDV coinfection                       │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Uremia patients under hemodialysis or continuous   │ Uremia patients under hemodialysis or continuous   │     100 │
│ ambulatory peritoneal dialysis or patients with    │ ambulatory peritoneal dialysis or patients with    │         │
│ Ccr \< 50 mL/min                                   │ Ccr < 50 mL/min                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Pregnant or breastfeeding women                    │ Pregnant or breastfeeding women                    │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Women of child-bearing potential (WOCBP) who are   │ Women of child-bearing potential (WOCBP) who are   │     100 │
│ unwilling or unable to use an acceptable method of │ unwilling or unable to use an acceptable method of │         │
│ contraception to avoid pregnancy throughout the    │ contraception to avoid pregnancy throughout the    │         │
│ study and for up to 4 weeks after the last dose of │ study and for up to 4 weeks after the last dose of │         │
│ study drug                                         │ study drug                                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Uncontrolled HCC or other malignancy within 3      │ HCC or other malignancy within 3 years             │      85 │
│ years                                              │                                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ HBsAg-positive for more than 6 months and HBV DNA  │ HBsAg-positive for more than 6 months and HBV DNA  │      98 │
│ \< 2000 IU/ml (Subgroup 1）or HBsAg-negative but   │ < 2000 IU/ml (Subgroup 1)or HBsAg-negative but     │         │
│ anti-HBc positive with HBV DNA \< 2000 IU/ml       │ anti-HBc positive with HBV DNA < 2000 IU/ml        │         │
│ (Subgroup 2）                                      │ (Subgroup 2)                                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Decompensated liver cirrhosis (CTP score ≥ 7)      │ Decompensated liver cirrhosis (CTP score = 7)      │      98 │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                          │   Score │
╞═══════════════════════════════════╪════════════════════════════════════════╪═════════╡
│ Must have minimum age of 20 Years │ HCC or other malignancy within 3 years │      42 │
├───────────────────────────────────┼────────────────────────────────────────┼─────────┤
│ Must have maximum age of 90 Years │ HCC or other malignancy within 3 years │      42 │
╘═══════════════════════════════════╧════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 95
Average Levenshtein Ratio of individual lines: 87.72727272727273
OverAll Ratio: 91.36363636363637
